200-037-4

Applied Filters:

Keyword:'200-037-4'

Showing 1-2 of 2 results for "200-037-4" within Papers

Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.

Victor L Villemagne et al.

The Lancet. Neurology, 12(4), 357-367 (2013-03-13)

Similar to most chronic diseases, Alzheimer's disease (AD) develops slowly from a preclinical phase into a fully expressed clinical syndrome. We aimed to use longitudinal data to calculate the rates of amyloid β (Aβ) deposition, cerebral atrophy, and cognitive decline.

FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study.

Anu Suomalainen et al.

The Lancet. Neurology, 10(9), 806-818 (2011-08-09)

Muscle biopsy is the gold standard for diagnosis of mitochondrial disorders because of the lack of sensitive biomarkers in serum. Fibroblast growth factor 21 (FGF-21) is a growth factor with regulatory roles in lipid metabolism and the starvation response, and

Page 1 of 1